Abstract
The phospholipid composition of erythrocyte membranes from patients with multiple sclerosis (MS) was found to be normal, in agreement with previous reports. The transbilayer asymmetry of the glycerophospholipids in MS red cells was probed using bee venom phospholipase A2 and was also found not to be significantly different from normal. Abnormal membrane glycerophospholipid organisation is therefore not involved in the increased red cell size, osmotic fragility, and electrophoretic mobility associated with MS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Prineas, J. 1968. Red blood cell size in multiple sclerosis. Acta Neurol. Scand. 44:81–90.
Plum, C. M., andFog, T. 1959. Studies in multiple sclerosis. Acta Psych. Neurol. Scand. (Suppl. 128) 34:13–14.
Caspary, E. A., Sewell, F., andField, E. J. 1967. Red blood cell fragility in multiple sclerosis. Brit. Med. J. 2:610–611.
Stasiw, D. M., Rosato, S., Mazza, J., andCerny, L. C. 1977. Quantitative osmotic fragility and disease states: a preliminary study. J. Lab. Clin. Med. 89:409–413.
Kurantsin-Mills, J., Samji, N., Moscarello, M. A., andBoggs, J. M. 1982. Comparison of membrane structure, osmotic fragility and morphology of multiple sclerosis and normal erythrocytes. Neurochem. Res. 7:1523–1540.
Sanders, H., Thompson, R. H. S., Wright, H. P., andZilkha, K. J. 1968. Further studies on platelet adhesiveness and serum cholesteryl linoleate levels in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 31:321–325.
Millac, P. 1967. Platelet stickiness in multiple sclerosis Dtsch. Z. Nervenheilk. 191:74–79.
Lux, S. E. 1979. Spectrin-actin membrane skeleton of normal and abnormal red blood cells. Sem. Hematol. 16:21–51.
Haest, C. W. M., Plasa, G., Kamp, D. andDeuticke, B. 1978. Spectrin as a stabilizer of the phospholipid asymmetry in the human erythrocyte membrane. Biochim. Biophys. Acta. 509:21–32.
Homa, S. T., Belin, J., Smith, A. D., Monro, J. A., andZilkha, K. J. 1980. Levels of linoleate and arachidonate in red blood cells of healthy individuals and patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 43:106–110.
Gordesky, S. E., andMarinetti, G. V. 1973. The asymmetric arrangement of phospholipids in the human erythrocyte membrane. Biochem. Biophys. Res. Comm. 50:1027–1031.
Dodge, J. T., Mitchell, C., andHanahan, D. J. 1963. The preparation and chemical characteristics of haemoglobin-free ghosts of human erythrocytes Arch. Biochem. Biophys. 100:119–130.
Roelofsen, B., andZwaal, R. F. A. 1977. The use of phospholipases in the determination of asymmetric phospholipid distribution in membranes. Meths. Membr. Biol. 7:147–177.
Broekhuyse, R. M. 1969. Quantitative two-dimensional thin-layer chromatography of blood phospholipids. Clin. Chim. Acta 23:457–461.
Rouser, G., Fleischer, S., andYamamoto, A. 1969. Two-dimensional thin-layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494–496.
Shukla, V. K. S., Jensen, G. E., andClausen., J. 1977. Erythrocyte glutathione peroxidase deficiency in multiple sclerosis. Acta Neurol. Scand. 56:542–550.
May, H. E., andMcCay, P. B. 1968. Reduced triphosphopyridine nucleotide oxidasecatalysed alterations of membrane phospholipids I. Nature of the lipid alterations. J. Biol. Chem. 243:2288–2295.
Tappel, A. L. 1968. Protection against free radical lipid peroxidation reactions. Adv. Exp. Med. Biol. 97:111–131.
Lubin, B., Chu, D., Bastacky, J., Roelofsen, B., andvan Deenen, L. L. M. 1981. Abnormalities in membrane phospholipid organisation in sickled erythrocytes. J. Clin. Invest. 67:1643–1649.
Hunter, M. I. S., Lao, M. S., andDe Vane, P. J. 1983. Is erythrocyte membrane phospholipid organisation abnormal in Duchenne muscular dystrophy? Clin. Chim. Acta 128:69–74.
Field, E. J., Shenton, B. K., andJoyce, G. 1974. Specific laboratory test for diagnosis of multiple sclerosis. Brit. Med. J. 1:412–414.
Field, E. J., andJoyce, G. 1976. Simplified laboratory test for multiple sclerosis. Lancet ii, Aug. 14:367–368.
Seaman, G. V. F., Swank, R. L., andTamblyn, C. H. 1980. Plasma origin of red-cell membrane changes in multiple sclerosis. Lancet, i, April 26:938.
Field, E. J., andJoyce, G. 1982. An office test for multiple sclerosis. IRCS Med. Sci. 10:560–561.
Zukoski, C. F., Tamblyn, C. H., Swank R. L., andSeaman, G. V. F. 1979. The basis for the unsaturated fatty acid red cell electrophoretic mobility test for multiple sclerosis. Pages 302–312.in Preece, A. W., andSabolovic, D. (eds.) Cell Electrophoresis: Clinical Application and Methodology. North Holland, Amsterdam.
Field, E. J., andJoyce, G. 1979. Erythrocyte membrane anomaly in Duchenne muscular dystrophy. IRCS Med. Sci. 1:73.
Wilkerson, L. S., Perkins, R. C., Roelofs, R., Swift, L., Dalton, L. R., andPark, J. H. 1978. Erythrocyte membrane abnormalities in Duchene muscular dystrophy monitored by saturation transfer electron paramagnetic resonance spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 75:838–841.
Laurent, M., Daveloose, D., Leterrier, F., Fischer, S., Schapira, G. 1980. A spin label study of the erythrocyte membranes in Duchenne muscular dystrophy. Clin. Chim. Acta 105:183–194.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunter, M.I.S., Lao, M.S. & Davidson, D.L.W. Erythrocyte membrane glycerophospholipid organization is normal in multiple sclerosis. Neurochem Res 9, 103–108 (1984). https://doi.org/10.1007/BF00967662
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00967662